Merit Medical Acquires View Point to Expand Oncology Devices
SOUTH JORDAN, Utah, April 1, 2026 Merit Medical Systems, Inc. has announced the acquisition of View Point Medical, Inc....
AI in Healthcare Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
SOUTH JORDAN, Utah, April 1, 2026 Merit Medical Systems, Inc. has announced the acquisition of View Point Medical, Inc....
AMSTERDAM, Netherlands, March 26, 2026 Royal Philips announced that the U.S. Food and Drug Administration (FDA) has granted 510(k)...
CHICAGO, ILLINOIS, March 23, 2026 GE HealthCare has announced that the U.S. Food and Drug Administration (FDA) has granted...
Raleigh, N.C. | January 28, 2026 — Lumexa Imaging, one of the largest U.S. providers of outpatient diagnostic imaging...
Boston, Massachusetts, January 21, 2026 — Aidoc, a global leader in clinical artificial intelligence, announced that the U.S. Food...
VANCOUVER, BC, Dec. 17, 2025 — Clarius Mobile Health, a global leader in AI-powered handheld ultrasound technology, reported a...
mlHealth 360 has received U.S. FDA 510(k) clearance for Scaida BrainCT-ICH, the first Canada-developed AI-powered triage solution designed to...
